LASER
| Design of Registry: |
multicenter, prospective Registry, Follow Up |
| Inclusion criteria: |
- Patients with significant symptomatic coronary artery disease (stable angina class II or more (CCS), unstable angina, NSTEMI, or STEMI) and who for this reason do undergo percutaneous coronary revascularization with one or more drug eluting stent(s) (DES) or bare metal stent(s)
- Patients requiring Vitamin K Antagonists based full anticoagulation therapy (target INR 2-4,5) for any clinical indication
|
| Aim of Registry: |
On the collected data the LASER registry will
- document the frequently used treatment modalities how patients requiring stents on the background of full anticoagulation with Vitamin K Antagonists are currently managed
- document the associated cardiac event rates with each currently used treatment strategy
- document the associated bleeding rates with each currently used treatment strategy
|
| Number of patients: |
The LASER Registry will collect the data of 1000 patients with the need for oral anticoagulation and 1000 matched control patients without the need for oral anticoagulation.
|
| Length of study: |
Patient recruitment started November 1st, 2008. Recruitment will stop after 1000 consecutive patients have been enrolled unless the sample size is increased or the registry is prematurely terminated by the steering committee.
|
| Participating centers: |
37 centers in 9 countries |
|
